|
Real-time Estimate
Cboe BZX
09:13:52 2026-08-28 EDT
|
5-day change | 1st Jan Change | ||
| 66.28 USD | +2.55% |
|
0.00% | +20.00% |
| 05:52am | Cytokinetics eyes expanded use of heart drug after promising late-stage data | RE |
| 08-25 | Bristol Myers ends blood cancer drug deal with cell therapy maker Cellares | RE |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| -1.12% | -5.49% | -1.79% | +8.60% | +9.44% | +60.19% | +112.43% | +352.78% | +1,403.20% | 1,048B | ||
| -1.57% | -0.60% | -0.07% | +14.91% | +28.42% | +50.33% | +59.86% | +53.69% | +123.26% | 640B | ||
| -1.81% | -1.41% | +0.48% | +19.85% | +12.98% | +24.07% | +75.98% | +115.88% | +299.55% | 456B | ||
| -0.92% | -3.83% | -1.82% | +9.82% | +10.05% | +38.39% | +39.38% | -1.26% | +49.26% | 362B | ||
| -0.29% | -2.40% | -4.63% | +5.16% | +13.47% | +22.47% | +37.48% | +47.92% | +59.74% | 295B | ||
| -0.54% | +0.28% | -6.24% | -13.44% | -12.38% | +1.78% | +11.84% | +40.83% | +143.86% | 255B | ||
| -0.76% | +0.75% | +16.14% | +30.03% | +33.51% | +51.75% | +70.45% | +96.15% | +154.11% | 236B | ||
| +0.58% | -0.98% | -11.18% | +1.46% | -8.41% | -16.97% | -53.92% | -7.51% | +90.23% | 204B | ||
| +0.52% | +3.78% | +14.05% | +11.35% | +21.28% | +30.67% | +93.68% | +108.84% | +86.61% | 185B | ||
| -0.99% | +0.83% | +13.58% | +6.91% | +12.53% | +11.77% | -22.98% | -39.87% | -19.53% | 160B | ||
| +0.05% | +1.35% | +14.31% | +25.23% | +20.78% | +40.73% | +56.42% | +173.88% | +463.96% | 139B | ||
| -0.92% | +2.26% | +7.02% | +16.39% | +24.12% | +40.56% | +7.84% | +0.53% | +13.92% | 137B | ||
| -0.19% | -2.29% | -2.83% | +1.01% | -6.76% | -9.64% | -22.31% | -12.41% | +11.09% | 108B | ||
| -0.35% | -3.47% | -5.69% | -3.92% | +1.37% | +25.86% | +32.32% | +0.07% | -10.30% | 101B | ||
| +1.24% | +2.15% | +2.70% | -7.29% | -14.68% | +17.00% | +59.37% | +64.13% | +552.21% | 71.75B | ||
| -0.15% | +0.54% | +0.54% | +14.62% | +19.96% | +31.76% | +29.70% | +58.25% | +29.20% | 58.22B | ||
| +0.67% | +1.67% | +3.85% | +29.07% | +31.96% | +74.90% | -3.06% | +3.61% | -49.48% | 55.48B | ||
| -0.58% | -11.23% | -13.02% | -5.95% | -21.96% | -29.84% | +14.17% | -1.94% | +183.98% | 46.67B | ||
| -0.58% | +2.68% | -0.73% | +7.49% | -1.95% | +2.71% | +12.52% | - | - | 44.23B | ||
| Average | -0.12% | -0.98% | +1.30% | +9.02% | +9.14% | +24.66% | +32.17% | +58.53% | +199.16% | 242.21B | |
| Weighted average by Cap. | -0.04% | -1.65% | +0.62% | +10.28% | +12.38% | +35.28% | +55.47% | +120.03% | +425.66% |
- Stock Market
- Stocks
- BMY Stock
- BMYUS Stock
- Sector Bristol-Myers Squibb Company
Select your edition
All financial news and data tailored to specific country editions
















